Literature DB >> 31156826

The role of a pharmacist in a hospice: a nationwide survey among hospice directors, pharmacists and physicians.

Iga Pawłowska1, Leszek Pawłowski2, Monika Lichodziejewska-Niemierko2.   

Abstract

BACKGROUND: Palliative care requires the collaborative efforts of an interdisciplinary team, and as such a range of health professionals should be involved in supporting patients with life-threatening diseases. As a part of this therapeutic network, pharmacists at residential hospices should be thoroughly involved in care, cooperate with other medical staff and perform pharmaceutical services in order to deliver safe and efficient pharmacotherapy. AIM: To provide an overview of the current state of pharmacy practice at Polish residential hospices.
METHODS: A cross-sectional study was applied and three types of anonymous questionnaires were developed to collect data. Hospice directors, pharmacists and physicians from all residential hospices in Poland were invited to participate.
RESULTS: 19 (61%) hospices collaborate with at least one pharmacist, who performs pharmaceutical services on the premises. 12 (75%) pharmacists provide advice concerning medicines and 11 (69%) are involved in various roles related to procurement, dispensing and storage of drugs, as well as creating procedures for these activities. Despite pharmacists' great level of involvement in drug policy, most of them are not members of the therapeutic team and they do not participate in ward rounds. Furthermore, the provision of clinical pharmaceutical services forms a minority of Polish hospital pharmacy practice.
CONCLUSIONS: Although the role of a hospice-based pharmacist is focused on the provision of drugs, it should become more clinical, that is, more patient oriented. The data obtained should be used as a source of information for implementing potential changes to palliative care pharmacy.

Entities:  

Keywords:  CLINICAL PHARMACOLOGY; DRUG PROCUREMENT; DRUG STORAGE AND DISTRIBUTION; PHARMACY MANAGEMENT (PERSONNEL)

Year:  2015        PMID: 31156826      PMCID: PMC6451534          DOI: 10.1136/ejhpharm-2015-000730

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  16 in total

1.  The role of the pharmacist in palliative care: results of a survey conducted in Australia and Canada.

Authors:  Peter Gilbar; Kimberley Stefaniuk
Journal:  J Palliat Care       Date:  2002       Impact factor: 2.250

Review 2.  Administering, analysing, and reporting your questionnaire.

Authors:  Petra M Boynton
Journal:  BMJ       Date:  2004-06-05

Review 3.  Selecting, designing, and developing your questionnaire.

Authors:  Petra M Boynton; Trisha Greenhalgh
Journal:  BMJ       Date:  2004-05-29

4.  Fifty reasons to love your palliative care pharmacist.

Authors:  Kathryn A Walker; Laura Scarpaci; Mary Lynn McPherson
Journal:  Am J Hosp Palliat Care       Date:  2010-05-27       Impact factor: 2.500

5.  According to the 2002 WHO definition of palliative care...

Authors:  Vittorio Ventafridda
Journal:  Palliat Med       Date:  2006-04       Impact factor: 4.762

6.  ASHP statement on the pharmacist's role in hospice and palliative care.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2002-09-15       Impact factor: 2.637

7.  Impact of pharmacist intervention on clinical outcomes in the palliative care setting.

Authors:  Shelley Wilson; Robert Wahler; Jack Brown; Fred Doloresco; Scott V Monte
Journal:  Am J Hosp Palliat Care       Date:  2010-11-28       Impact factor: 2.500

8.  The palliative care interdisciplinary team: where is the community pharmacist?

Authors:  Moira O'Connor; Judith Pugh; Moyez Jiwa; Jeff Hughes; Colleen Fisher
Journal:  J Palliat Med       Date:  2011-01       Impact factor: 2.947

9.  Team working: palliative care as a model of interdisciplinary practice.

Authors:  Gregory B Crawford; Sharonne D Price
Journal:  Med J Aust       Date:  2003-09-15       Impact factor: 7.738

10.  The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians.

Authors:  Sander D Borgsteede; Christiaan A Rhodius; Peter A G M De Smet; H Roeline W Pasman; Bregje D Onwuteaka-Philipsen; Mette L Rurup
Journal:  Eur J Clin Pharmacol       Date:  2010-09-19       Impact factor: 2.953

View more
  2 in total

1.  Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.

Authors:  Magdalena Cerbin-Koczorowska; Magdalena Waszyk-Nowaczyk; Piotr Przymuszała
Journal:  Int J Environ Res Public Health       Date:  2020-09-12       Impact factor: 3.390

2.  The Development of an Enhanced Palliative Care Pharmacy Service during the Initial COVID-19 Surge.

Authors:  Jaquie Hanley; Maureen Spargo; Joanne Brown; Julie Magee
Journal:  Pharmacy (Basel)       Date:  2021-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.